ArticleFrontiers in nutrition2025
Coffee consumption as a double-edged sword for serum lipid profile: findings from NHANES 2005-2020.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is growing interest in coffee's impact on cardiovascular health. As dyslipidemia is a major modifiable risk factor for cardiovascular disease and coffee may influence lipid metabolism, exploring the association between coffee consumption and serum lipid profile may provide further insights into coffee's cardiovascular effects and help inform dietary recommendations for patients with cardiovascular disease. Materials and methods: Cross-sectional data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2005-2020. The exposure variable was the daily coffee consumption, measured in cups, and the outcome variables were serum lipid profile components, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). Weighted multiple linear regression, subgroup and interaction analyses, and restricted cubic spline (RCS) regression were used to evaluate the associations. Sensitivity analyses were conducted to assess the robustness of the results. Results: Each additional cup of coffee consumed per day was associated with a 1.23 mg/dl increase in TC (95% CI: 0.68, 1.77) and a 1.22 mg/dl increase in LDL-C (95% CI: 0.77, 1.67). In the categorical analysis, among participants consuming ≥3 cups/day, each additional cup of coffee was linked to an increase of 8.45 mg/dl in TC (95% CI: 4.94, 11.96) and 7.86 mg/dl in LDL-C (95% CI: 5.01, 10.72), compared with non-drinkers. In females, HDL-C levels rose with coffee consumption up to 2.6 cups/day, after which they began to decline, showing an inverted U-shaped association. In males, a similar non-linear trend was observed for TG, with levels peaking at 3.0 cups/day before decreasing. Conclusion: Coffee consumption exerts both beneficial and adverse effects on serum lipid profile. While it is positively associated with elevated TC and LDL-C levels, its relationships with HDL-C and TG are more complex and gender-specific. In females, HDL-C increased with intake up to 2.6 cups/day and declined thereafter, forming an inverted U-shaped pattern. In males, TG followed a similar trend, peaking at 3.0 cups/day. Although these changes were statistically significant, their clinical relevance may vary depending on individual cardiovascular risk profiles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.